1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
This listing may be outdated. Verify details at the official source before applying.
Find similar grantsSmall Business Innovation Research (SBIR) Program (National Institute of Mental Health - NIMH) is sponsored by National Institute of Mental Health (NIMH), National Institutes of Health (NIH). The NIMH SBIR program supports small businesses in conducting high-quality, advanced research and development of innovative technologies in neuroscience and mental health.
Get a weekly digest of new grants like this
A free weekly digest of new foundation and federal funding opportunities as they're added to Granted. Unsubscribe anytime.
Or search similar grants →Extracted from the official opportunity page/RFP to help you evaluate fit faster.
Small Business Research - National Institute of Mental Health (NIMH) NIH Websites Are Changing Opportunities & Announcements Funding Strategy for Grants Grant Writing & Approval Process Program staff encourage potential applicants to contact us in the early stages of application planning to determine programmatic fit and to provide support in preparing a strong application.
Please email a draft Specific Aims page to help us connect you with the appropriate staff and ensure efficient communication. The mission of the National Institute of Mental Health (NIMH) is to transform the understanding and treatment of mental illnesses through basic and clinical research, paving the way for prevention, recovery, and cure.
The goal of the NIMH Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) programs is to support small businesses to develop technologies that can advance the mission of the Institute, including: Basic neuroscience research Translational and clinical research Clinical diagnosis and treatment Dissemination and implementation of evidence-based research on mental disorders.
NIMH SBIR/STTR Program Staff are committed to working with applicants and awardees to support research and development of innovative technologies by small businesses that have the potential to succeed commercially or to provide significant societal benefits, in the areas of neuroscience and mental health. What are the SBIR & STTR programs?
The Small Business Innovation Research (SBIR) & Small Business Technology Transfer (STTR) Programs are one of the largest sources of early-stage capital for technology commercialization in the United States. These programs support research and development by small businesses of innovative technologies that have the potential to succeed commercially or provide significant societal benefits. To learn more, visit the SBIR Program website .
Difference between SBIR and STTR SBIR STTR Partnering Requirement Permits partnering Requires a non-profit research institution partner Principal Investigator Primary employment (>50%) must be with the small business PI may be employed by either the research institution partner or small business Work Requirement Subcontracts generally up to: 30% Research Institution Partner The small business is ALWAYS the applicant and awardee.
According to the current listing, eligibility includes: Small businesses with a focus on innovative technologies that can advance the NIMH mission. Primary employment (>50%) for the Principal Investigator must be with the small business. Confirm the full requirements in the official notice before applying.
Small Business Innovation Research (SBIR) Program (National Institute of Mental Health - NIMH) is funded by National Institute of Mental Health (NIMH), National Institutes of Health (NIH). Verify program details on the funder's official page before applying.
Start from the official opportunity page linked in this listing — it carries the sponsor's submission instructions.
BRAIN Initiative: Reagent Resources for Brain Cell Type-Specific Access to Broaden Distribution of Enabling Technologies for Neuroscience (U24 Clinical Trial Not Allowed) is sponsored by National Institute of Mental Health (NIMH), National Institutes of Health (NIH). This funding opportunity supports the establishment of facilities, particularly at minority-serving institutions, to develop and broadly distribute reagent resources for brain cell type-specific access, thereby advancing neuroscience research through innovative neurotechnologies.
School Mental and Behavioral Health: Expanding Access to Evidence-Based Interventions and Services is sponsored by National Institute of Mental Health (NIMH), National Institutes of Health (NIH). This highlighted topic encourages research focused on optimizing and testing school-based mental and behavioral health interventions and service delivery models. It emphasizes research-informed approaches that can be rapidly deployed and sustained in school and afterschool program settings using available resources and personnel. Relevant research includes validating sustainable strategies for operationalizing mental health risk, detecting students at risk, and matching students to appropriate interventions and services, including referring to specialty mental health care when needed.
Development of Psychosocial Therapeutic and Preventive Interventions for Mental Disorders (R61/R33 Clinical Trial Required) is sponsored by National Institute of Mental Health (NIMH), National Institutes of Health (NIH). This funding opportunity supports early-stage, clinically grounded research to create and refine new psychosocial interventions and prevention strategies for mental disorders, with a required clinical trial component. It emphasizes an experimental therapeutics approach, focusing on clearly defined intervention targets and demonstrating target engagement in relation to clinical outcomes. The R61 phase provides up to two years for preliminary testing of target engagement, and the R33 phase provides up to three additional years to replicate target engagement and test its association with changes in clinical outcomes.
The Health and Extreme Weather highlighted topic went live September 1, 2026 with eleven awarding institutes and expires May 1, 2028. There is no set-aside, no separate deadline, and no review criteria — which makes the institute-by-institute language the only real signal, and it is not uniform.
Read articleThe NOURISH Autoimmunity Digital Health Challenge runs three phases to August 2028: 10 winners at $20,000, then 5 at $30,000, then 3 at $100,000. It is a prize competition, not a grant — no indirect costs, no cost reimbursement, and a rule that quietly disqualifies the obvious applicant.
Read articlePMHCA (HRSA-26-058) makes $9.79 million available for up to 22 awards of up to $445,000 to build tele-consultation networks that help pediatric primary care providers manage children's behavioral health. The catch buried in the eligibility section: applicants must NOT already hold a PMHCA award — which effectively reserves the new-state lane for the eight unfunded states and territories, plus tribes everywhere. Here's how to read it and what wins.
Read article